Epstein-Barr virus and the immune system. Hide and seek

JAMA. 1997 Aug 13;278(6):510-3.
No abstract available

Publication types

  • Case Reports
  • Clinical Conference

MeSH terms

  • Adult
  • Antigen Presentation
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • B-Lymphocytes / physiology
  • B-Lymphocytes / virology*
  • Burkitt Lymphoma / drug therapy
  • Burkitt Lymphoma / immunology*
  • Burkitt Lymphoma / virology
  • Cell Adhesion Molecules
  • Epstein-Barr Virus Nuclear Antigens* / genetics
  • Epstein-Barr Virus Nuclear Antigens* / metabolism
  • Gene Expression
  • Genes, MHC Class I
  • Genes, Viral
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / physiology*
  • Humans
  • Immunocompetence
  • Interleukin-10 / physiology
  • Killer Cells, Natural / physiology
  • Male
  • T-Lymphocytes, Cytotoxic / physiology
  • Viral Matrix Proteins* / genetics
  • Viral Matrix Proteins* / metabolism
  • Viral Proteins
  • Virus Latency / physiology*

Substances

  • Cell Adhesion Molecules
  • EBV-associated membrane antigen, Epstein-Barr virus
  • Epstein-Barr Virus Nuclear Antigens
  • Viral Matrix Proteins
  • Viral Proteins
  • Interleukin-10